← Eichor
Study identifier: NCT04666714 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain

Condition: Neuropathic Pain  ·  Sponsor: EMS

PhasePhase 3
Planned participants136
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy and safety of Praga formulation in the treatment of neuropathic pain.

This description comes directly from the study's public registry record.

Talk to the study team

Monalisa FB Oliveira, MD  ·  +551938879851  ·  pesquisa.clinica@ncfarma.com.br

Always discuss trial participation with your own doctor first.

Locations (1)

AllegisaCampinas, São Paulo, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04666714